Taiwanese Journal of Obstetrics and Gynecology
Volume 45, Issue 4 , Pages 325-328, December 2006

Concurrent Use of Mifepristone and Misoprostol for Early Medical Abortion

  • Yiu-Tai Li

      Affiliations

    • Department of Obstetrics and Gynecology, Taipei, Taiwan
    • ,
  • Fu-Min Chen

      Affiliations

    • Department of Obstetrics and Gynecology, Chung Shan Hospital, Taipei, Taiwan
    • ,
  • Tien-Hui Chen

      Affiliations

    • Department of Obstetrics and Gynecology, Taipei, Taiwan
    • ,
  • Shu-Ching Li

      Affiliations

    • Department of Nursing, Kuo General Hospital, Tainan, Taiwan
    • ,
  • Min-Lung Chen

      Affiliations

    • Department of Obstetrics and Gynecology, Taipei, Taiwan
    • Corresponding Author InformationCorrespondence to: Dr Min-Lung Chen, Department of Obstetrics and Gynecology, Kuo General Hospital, 22, Ming-Sheng Road, Section 2, Tainan 700, Taiwan
    • ,
  • Tsung-Cheng Kuo

      Affiliations

    • Department of Obstetrics and Gynecology, Taipei, Taiwan

Accepted 27 October 2006.

Article Outline

Summary 

Objective

This study was designed to evaluate the efficacy of using mifepristone and misoprostol concurrently for early medical abortion.

Materials and Methods

A total of 90 women with undesired pregnancies ≤ 49 days' gestation were enrolled. All women concurrently received oral mifepristone 200 mg and vaginal misoprostol 800 mg. Follow-up evaluation with transvaginal ultrasonography was performed 4 days and 2 weeks after treatment.

Results

The complete abortion rate was 97.8% (88/90 women). The mean induction to abortion interval was 5.5 hours. The mean bleeding duration was 11.8 days. Patients found the side effects acceptable and reported a 91.1% (82 patients) satisfaction rate.

Conclusion

Concurrent administration of oral mifepristone and vaginal misoprostol is an efficacious regimen for medical abortion of pregnancies ≤ 49 days of gestation.

Key Words:  concurrent medical abortion , mifepristone , misoprostol

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. El-Refaey H , Rajasekar D , Abdalla M , Calder L , Templeton A . Induction of abortion with mifepristone (RU486) and oral or vaginal misoprostol . N Engl J Med . 1995;332:983–987
  2. Peyron R , Aubeny E , Targosz V , et al.   Early termination of pregnancy with mifepristone (RU486) and the orally active prostaglandin misoprostol . N Engl J Med . 1993;328:1509–1513
  3. Kahn JG , Beaker BJ , Maclsaa L , et al.   The efficacy of medical abortion: a meta-analysis . Contraception . 2000;61:29–40
  4. Lin HW , Chien TY , Jeng CJ , Chen SC , Chen HF , Hwang JL . Comparison of two doses of mifepristone in combination with misoprostol for early pregnancy termination . Taiwanese J Obstet Gynecol . 2002;41:155–161
  5. Swahn ML , Wang G , Aedo AR , Cekan SZ , Bygdeman M . Plasma levels of antiprogestin RU 486 following oral administration to non-pregnant and early pregnant women . Contraception . 1986;34:469–481
  6. Shi YE , Ye ZH , He CH , et al.   Pharmacokinetic study of RU 486 and its metabolite after oral administration of single doses to pregnant and non-pregnant women . Contraception . 1993;48:133–149
  7. Marions L . Mifepristone dose in the regimen for medical abortion . Contraception . 2006;74:21–25
  8. Zieman M , Fong SK , Benowitz NL , Banskter D , Darney PD . Absorption kinetics of misoprostol with oral or vaginal administration . Obstet Gynecol . 1997;90:88–92
  9. Schaff E . Evidence for shortening the time interval of prostaglandin after mifepristone for medical abortion . Contraception . 2006;74:42–44
  10. Jain JK , Dutton C , Harwood B , Meckstroth KR , Mishell DR . A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy . Hum Reprod . 2002;17:1477–1482
  11. Murthy AS , Creinin MD , Harwood B , Schreiber C . A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation . Contraception . 2005;71:333–336
  12. Schreiber CA , Creinin MD , Harwood B , Murthy AS . A pilot study of mifepristone and misoprostol administered at the same time for abortion in women with gestation from 50 to 63 days . Contraception . 2005;71:447–450
  13. Kapp N , Borgatta L , Ellis SC , Stubblefield P . Simultaneous very low dose mifepristone and vaginal misoprostol for medical abortion . Contraception . 2006;73:525–527

PII: S1028-4559(09)60252-7

doi:10.1016/S1028-4559(09)60252-7

Taiwanese Journal of Obstetrics and Gynecology
Volume 45, Issue 4 , Pages 325-328, December 2006

Article Tools